Predictors of ICS/LABA prescribing in COPD patients: a study from general practice
Background:
A combination of inhaled corticosteroid and long-acting beta2 agonist (ICS/LABA) is used frequently to treat chronic obstructive pulmonary disease (COPD) patients. The aim of the study was to determine whether prescribing ICS/LABA to COPD patients in primary care in 2009/10 was within the GOLD guidelines and whether and to what degree patient characteristics were associated with prescription of these drugs by GPs.
Methods:
This was a cross-sectional study in seven Norwegian GP practices. Patients registered with a diagnosis of asthma or COPD in the previous five years were included.
Results:
Among the 376 patients included in the analysis, 149 patients had COPD, defined as a post-bronchodilator FEV1/FVC
Source: BMC Family Practice - Category: Primary Care Authors: Elin DrivenesAnders ØstremHasse Melbye Source Type: research
More News: Asthma | Chronic Obstructive Pulmonary | Corticosteroid Therapy | Family Practices | General Practices | Primary Care | Study